CITANEST FORTE DENTAL Drug Patent Profile
When do Citanest Forte Dental patents expire, and when can generic versions of Citanest Forte Dental launch?
Citanest Forte Dental is a drug marketed by Dentsply Pharm and is included in one NDA.
The generic ingredient in CITANEST FORTE DENTAL is epinephrine bitartrate; prilocaine hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the epinephrine bitartrate; prilocaine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CITANEST FORTE DENTAL?
- What are the global sales for CITANEST FORTE DENTAL?
- What is Average Wholesale Price for CITANEST FORTE DENTAL?
Summary for CITANEST FORTE DENTAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 5 |
| DailyMed Link: | CITANEST FORTE DENTAL at DailyMed |
US Patents and Regulatory Information for CITANEST FORTE DENTAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dentsply Pharm | CITANEST FORTE DENTAL | epinephrine bitartrate; prilocaine hydrochloride | INJECTABLE;INJECTION | 021383-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
